Sanctuary Advisors’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,256
Closed -$84.2K 2597
2025
Q4
$84.2K Sell
16,256
-8,801
-35% -$42.6K ﹤0.01% 2350
2025
Q3
$106K Sell
25,057
-13,358
-35% -$62.1K ﹤0.01% 2342
2025
Q2
$141K Buy
+38,415
New +$143K ﹤0.01% 2231

Other funds holding ORGO

Sanctuary Advisors's ORGO Position: Q1 2026 in Review

Sanctuary Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 16,256 shares — an estimated $84.2K sold.

Sanctuary Advisors first reported a position in ORGO in Q2 2025 and held it in 3 quarters. The position peaked at $141K in Q2 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Sanctuary Advisors reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 16,256 Organogenesis Holdings shares in Q1 2026, an estimated $84.2K.
  • Sanctuary Advisors first reported a position in Organogenesis Holdings in Q2 2025 and held it in 3 quarters.
  • Sanctuary Advisors's Organogenesis Holdings position peaked at $141K in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.